A series of gene therapies expected to be commercialized with 65 clinical trials
It seems a series of products will be commercialized as the Ministry of Food and Drug Safety(MFDS) approved 65 cases of clinical trials for gene therapy development.
The MFDS approved Kolon Life Science’s ‘Invossa K Inj’ as the 1st Korean gene therapy on July 217. Invossa K Inj is a knee osteoa...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
